Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atrasentan Extension Study in Hormone Refractory Prostate Cancer
NCT00127478Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Jul 2001
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of atrasentan in prostate adenocarcinoma, sponsored by Abbott Laboratories. Started Jul 2001; status: completed.
02
Drugs
atrasentan
03
Conditions
prostate adenocarcinoma
Beyond the preview
Go deeper on NCT00127478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00127478.